Systematic Protein Level Regulation via Degradation Machinery Induced by Genotoxic Drugs.

Area of Science:

• Proteomics
• Molecular Biology
• Cancer Drug Research

Background:

• Genotoxic drugs are crucial in cancer therapy.
• Understanding their impact on cellular proteomes is vital.
• Protein dynamics following drug exposure remain incompletely understood.

Purpose of the Study:

• To comprehensively map protein dynamics induced by genotoxic drugs.
• To investigate the coordinated regulation of protein levels.
• To identify the role of protein degradation in drug response.

Main Methods:

• Utilized reverse-phase protein arrays (RPPAs) to monitor protein dynamics.
• Analyzed 666 protein time-courses across various drug concentrations and modes.
• Employed correlation distance (dCor) to assess similarity in protein level dynamics.

Main Results:

• 38% of proteins showed increasing trends, 32% decreasing, and 30% fluctuating within 24h.
• 22% of protein pairs exhibited highly correlated dynamics (dCor > 0.8).
• Proteasome inhibition (MG132) disrupted these trends, indicating activation of protein degradation.

Conclusions:

• Genotoxic drugs induce widespread protein dynamics, with many proteins regulated coordinately.
• Apoptosis-related proteins showed significantly higher correlation in their dynamics.
• Common protein degradation machinery is likely involved in regulating protein levels in response to genotoxic stress.